Our CEO Pascal Soriot talks to CNBC’s Julianna Tatelbaum, outlining the strategy behind AstraZeneca’s return to growth and how scientific leadership will continue to underpin the company’s success for years to come. He also offers his thoughts on the pharma industry’s reputation, US pricing and access, Brexit, emerging markets and China.
----------------------------------------
Global site: [ Ссылка ]
Careers site: [ Ссылка ]
Follow us:
Twitter: [ Ссылка ]
LinkedIn: [ Ссылка ]
Instagram: [ Ссылка ]
Facebook: [ Ссылка ]
